CD19 Antikörper (PE)
Kurzübersicht für CD19 Antikörper (PE) (ABIN2704188)
Target
Alle CD19 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Verwendungszweck
- CD19 PE Antibody
-
Produktmerkmale
- The clone 4G7 recognizes a 90- kDa CD19 antigen that is present on human B lymphocytes. The CD19 antigen is present on approximately 7 to 23 % of human peripheral blood lymphocytes at all stages of B cell maturation but is lost on terminally differentiated plasma cells. CD19 does not react with resting or activated T lymphocytes, granulocytes, or monocytes.
-
Aufreinigung
- Purified
-
Reinheit
- >95 %
-
Immunogen
- Human CCL (chronic lymphocytic leukemia) cells
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 25 μg/mL
-
Buffer
- PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 2-8°C, Conjugated antibodies should never be frozen.
-
-
- CD19 (CD19 Molecule (CD19))
-
Andere Bezeichnung
- CD19
-
NCBI Accession
- NM_001770
-
UniProt
- P15391
-
Pathways
- Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung
Target
-